The effect of silicone hydrogel contact lens composition on dexamethasone release
- 20 February 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 29 (2) , 222-233
Abstract
The relationship between the delivery of dexamethasone and the composition of silicone hydrogel materials was investigated. Two hydrophilic monomers (2-hydroxyethyl methacrylate or N,N-dimethylacrylamide), a siloxy methacrylate-based monomer (1-(Bis(trimethylsiloxy)methylsilyl)propoxy-3-metacryloxy-2-propanol, a polysiloxane (monomethacryloxypropyl-terminated polydimethylsiloxane) and a polymerizable silicone surfactant (Silmer ACR A008-UP) were used to synthesize silicone hydrogels of variable composition. The materials properties, such as surface wettability and equilibrium water content, were highly dependent on polymer composition. All dexamethasone-loaded hydrogels showed uptake that was driven primarily by sorption to the polymer phase. Furthermore, a positive correlation between loading mass and equilibrium water content was established. The duration of drug release from the hydrogels ranged from one to greater than two weeks depending on the monomer composition and relative contribution of hydrophilic and hydrophobic monomers. Higuchi model rate constants for the release showed strong correlation with the equilibrium water content, signifying that the release is likely controlled by aqueous phase diffusion.Keywords
This publication has 42 references indexed in Scilit:
- Extended drug delivery by contact lenses for glaucoma therapyJournal of Controlled Release, 2012
- Systemic toxicity of topical cyclopentolate eyedrops in a childEye, 2012
- Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl DeliveryMaterials, 2012
- Barriers to Glaucoma Drug DeliveryJournal of Glaucoma, 2008
- The Epidemiology of Contact Lens Related InfiltratesOptometry and Vision Science, 2007
- Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan®) in childrenEye, 2004
- Causes Of Non-Compliance With Drug Regimens In Glaucoma Patients: A Qualitative StudyJournal of Ocular Pharmacology and Therapeutics, 2002
- Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedropsGraefe's Archive for Clinical and Experimental Ophthalmology, 2002
- Ocular drug delivery conventional ocular formulationsAdvanced Drug Delivery Reviews, 1995
- Ocular absorption following topical deliveryAdvanced Drug Delivery Reviews, 1995